HDAC1 in axonal degeneration: A matter of subcellular localization

Cell Cycle

Volumn 9, Issue 18, 2010, Pages 3704-3708

  Kim, Jin Young ^a   Casaccia, Patrizia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelination; Histone deacetylase; Multiple sclerosis; Neurodegeneration; Nuclear export

Indexed keywords

ACETYL COENZYME A; ALPHA TUBULIN; AMYLOID PRECURSOR PROTEIN; ASPARTIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; EXCITATORY AMINO ACID; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 6; HUNTINGTIN; KINESIN 1; LEPTOMYCIN B; MOLECULAR MOTOR; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; N ACETYLASPARTIC ACID; SIRTUIN 2; TAU PROTEIN;

ACETYLATION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN ATROPHY; CELL FUNCTION; CELL NUCLEUS; CELL POLARITY; CELL SURVIVAL; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; CYTOPLASM; CYTOSOL; DEGENERATIVE DISEASE; DENDRITE; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUNTINGTON CHOREA; MICROTUBULE; MITOCHONDRION; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW;

EID: 77957013369     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.18.12716     Document Type: Review

References (42)

1. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation and neurodegeneration. Neuron 2006; 52:7-9.
2. Carswell R. Pathological anatomy: Illustrations of the elementary forms of disease. Longman, Orme, Brown, Green and Longman 1838.
3. Minagar A, Toledo EG, Alexander JS, Kelley RE. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis. J Neuroimaging 2004; 14:5-10.
4. Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging 2004; 14:27-35.
5. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48:893-901.
6. Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998; 20:271-6.
7. Sastre-Garriga J, Ingle GT, Chard DT, Ramio-Torrenta L, McLean MA, Miller DH, et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 2005; 62:569-73. (Pubitemid 40489887)
8. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 1999; 5:283-6. (Pubitemid 29405626)
9. Fisher E, Rudick RA, Cutter G, Baier M, Miller D, Weinstock-Guttman B, et al. Relationship between brain atrophy and disability: an 8 year follow-up study of multiple sclerosis patients. Mult Scler 2000; 6:373-7. (Pubitemid 32106796)
10. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120:393-9. (Pubitemid 27153632)
11. Roy S, Coffee P, Smith G, Liem RK, Brady ST, Black MM. Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J Neurosci 2000; 20:6849-61.
12. Lasek RJ, Garner JA, Brady ST. Axonal transport of the cytoplasmic matrix. J Cell Biol 1984; 99:212-21.
13. Cai D, Hoppe AD, Swanson JA, Verhey KJ. Kinesin-1 structural organization and conformational changes revealed by FRET stoichiometry in live cells. J Cell Biol 2007; 176:51-63. (Pubitemid 46041680)
14. Horiuchi D, Collins CA, Bhat P, Barkus RV, Diantonio A, Saxton WM. Control of a kinesin-cargo linkage mechanism by JNK pathway kinases. Curr Biol 2007; 17:1313-7. (Pubitemid 47176890)
15. Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesinbased motility. EMBO J 2002; 21:281-93. (Pubitemid 34137290)
16. Guillaud L, Wong R, Hirokawa N. Disruption of KIF17-Mint1 interaction by CaMKII-dependent phosphorylation: a molecular model of kinesin-cargo release. Nat Cell Biol 2008; 10:19-29.
17. Verhey KJ, Gaertig J. The tubulin code. Cell Cycle 2007; 6:2152-60.
18. LeDizet M, Piperno G. Identification of an acetylation site of Chlamydomonas alpha-tubulin. Proc Natl Acad Sci USA 1987; 84:5720-4.
19. Reed NA, Cai D, Blasius TL, Jih GT, Meyhofer E, Gaertig J, Verhey KJ. Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 2006; 16:2166-72.
20. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002; 417:455-8.
21. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003; 11:437-44.
22. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370:737-49.
23. Guardiola AR, Yao TP. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J Biol Chem 2002; 277:3350-6.
24. Gao L, Cueto MA, Asselbergs F, Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 2002; 277:25748-55.
25. Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci 2007; 27:3571-83.
26. Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007; 8:663-72.
27. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839-40.
28. Xiao S, McLean J, Robertson J. Neuronal intermediate filaments and ALS: a new look at an old question. Biochim Biophys Acta 2006; 1762:1001-12.
29. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003; 361:1642-4. (Pubitemid 36579005)
30. Miller KE, Sheetz MP. Axonal mitochondrial transport and potential are correlated. J Cell Sci 2004; 117:2791-804.
31. Kim JY, Shen S, Dietz K, He Y, Howell O, Reynolds R, Casaccia P. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 13:180-9.
32. McKinsey TA, Zhang CL, Olson EN. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol 2001; 21:6312-21.
33. Wen W, Meinkoth JL, Tsien RY, Taylor SS. Identification of a signal for rapid export of proteins from the nucleus. Cell 1995; 82:463-73.
34. Brandl A, Heinzel T, Kramer OH. Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 2009; 101:193-205.
35. Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J Biol Chem 2004; 279:7685-91. (Pubitemid 38294650)
36. Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, et al. HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell 2006; 22:669-79.
37. David G, Neptune MA, DePinho RA. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 2002; 277:23658-63. (Pubitemid 34952204)
38. Melchior F. SUMO - nonclassical ubiquitin. Annu Rev Cell Dev Biol 2000; 16:591-626.
39. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325:834.
40. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 1999; 98:675-86. (Pubitemid 29418958)
41. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 1997; 88:97-107. (Pubitemid 27180334)
42. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005; 6:889-98.